Dendreon Corp (NASDAQ:DNDN)
CAPS Rating:
A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.
A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.
Recs
Admittedly ignorant about biotechs. So, that is why it is here and not in my real portfolio.